Show simple item record

COMPARISON OF PURE ANTIBODY-MEDIATED REJECTION (AMR) WITH MIXED CELLULAR AND AMR IN REGARDS TO THE DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) AND CARDIOVASCULAR MORTALITY (CVM) IN HEART TRANSPLANT PATIENTS

dc.contributor.authorOzdemir, B. Handan
dc.contributor.authorAyva, Sebnem
dc.contributor.authorTerzi, Aysen
dc.contributor.authorSade, L. Elif
dc.contributor.authorBasturk, Bilkay
dc.contributor.authorSezgin, Atilla
dc.date.accessioned2020-10-20T11:16:46Z
dc.date.available2020-10-20T11:16:46Z
dc.date.issued2019
dc.identifier.issn0934-0874en_US
dc.identifier.urihttp://hdl.handle.net/11727/4945
dc.language.isoengen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleCOMPARISON OF PURE ANTIBODY-MEDIATED REJECTION (AMR) WITH MIXED CELLULAR AND AMR IN REGARDS TO THE DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) AND CARDIOVASCULAR MORTALITY (CVM) IN HEART TRANSPLANT PATIENTSen_US
dc.typeconferenceObjecten_US
dc.relation.journalTRANSPLANT INTERNATIONALen_US
dc.identifier.volume32en_US
dc.identifier.startpage213en_US
dc.identifier.endpage213en_US
dc.identifier.wos000491488703204en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record